CN Patent

CN105708819B — 医药制剂

Assigned to Array Biopharma Inc · Expires 2020-12-29 · 5y expired

What this patent protects

本发明涉及(S)‑甲基(1‑((4‑(3‑(5‑氯‑2‑氟‑3‑(甲基磺酰氨基)苯基)‑1‑异丙基‑1H‑吡唑‑4‑基)嘧啶‑2‑基)氨基)丙‑2‑基)氨基甲酸酯(化合物A)的固体口服医药制剂，和这些制剂于治疗增殖性疾病，例如实体肿瘤疾病，的用途。

USPTO Abstract

本发明涉及(S)‑甲基(1‑((4‑(3‑(5‑氯‑2‑氟‑3‑(甲基磺酰氨基)苯基)‑1‑异丙基‑1H‑吡唑‑4‑基)嘧啶‑2‑基)氨基)丙‑2‑基)氨基甲酸酯(化合物A)的固体口服医药制剂，和这些制剂于治疗增殖性疾病，例如实体肿瘤疾病，的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN105708819B
Jurisdiction
CN
Classification
—
Expires
2020-12-29
Drug substance claim
No
Drug product claim
No
Assignee
Array Biopharma Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.